We are live on ! Find out more
GDRX icon

GoodRx Holdings

192 hedge funds and large institutions have $5.14B invested in GoodRx Holdings in 2020 Q4 according to their latest regulatory filings, with 107 funds opening new positions, 51 increasing their positions, 18 reducing their positions, and 64 closing their positions.

New
Increased
Maintained
Reduced
Closed

183% more repeat investments, than reductions

Existing positions increased: 51 | Existing positions reduced: 18

67% more first-time investments, than exits

New positions opened: 107 | Existing positions closed: 64

50% more funds holding in top 10

Funds holding in top 10: 69 (+3)

29% more funds holding

Funds holding: 149192 (+43)

15.89% less ownership

Funds ownership: 305.43%289.54% (-16%)

24% less capital invested

Capital invested by funds: $6.73B → $5.14B (-$1.59B)

54% less call options, than puts

Call options by funds: $34.7M | Put options by funds: $76M

Holders
192
Holders Change
+43
Holders Change %
+28.86%
% of All Funds
3.4%
Holding in Top 10
9
Holding in Top 10 Change
+3
Holding in Top 10 Change %
+50%
% of All Funds
0.16%
New
107
Increased
51
Reduced
18
Closed
64
Calls
$34.7M
Puts
$76M
Net Calls
-$41.4M
Net Calls Change
-$39M
Name Holding Trade Value Shares
Change
Change in
Stake
Vontobel Holding
51
Vontobel Holding
Switzerland
$3.94M +$3.26M +70,968 New
MCM
52
McKinley Capital Management
Alaska
$3.55M +$1.61M +35,110 +66%
Citadel Advisors
53
Citadel Advisors
Florida
$3.45M -$822K -17,899 -17%
California Public Employees Retirement System
54
California Public Employees Retirement System
California
$3.13M +$3.56M +77,558 New
ECM
55
Endurant Capital Management
California
$3.12M +$3.55M +77,379 New
GCP
56
Greenoaks Capital Partners
California
$3.03M +$3.45M +75,000 New
Osaic Holdings
57
Osaic Holdings
Arizona
$2.95M +$3.19M +69,455 +1,900%
Northern Trust
58
Northern Trust
Illinois
$2.85M +$3.24M +70,600 New
RJA
59
Raymond James & Associates
Florida
$2.71M +$3.08M +67,090 New
Stifel Financial
60
Stifel Financial
Missouri
$2.7M +$2.85M +61,991 +1,229%
LCM
61
Laurion Capital Management
New York
$2.7M
Wells Fargo
62
Wells Fargo
California
$2.67M +$2.56M +55,620 +528%
RC
63
Renaissance Capital
Connecticut
$2.65M +$3.02M +65,638 New
Janus Henderson Group
64
Janus Henderson Group
United Kingdom
$2.5M +$2.85M +61,980 New
ECM
65
ExodusPoint Capital Management
New York
$2.42M +$2.25M +49,082 +449%
SL
66
SIB LLC
New York
$2.42M +$2.76M +60,000 New
VF
67
Virtu Financial
New York
$2.31M +$2.63M +57,174 New
Bank of Montreal
68
Bank of Montreal
Ontario, Canada
$2.27M -$345K -7,513 -12%
TW
69
TrinityPoint Wealth
Connecticut
$2.21M +$2M +43,594 New
EC
70
EMJ Capital
Ontario, Canada
$2.18M +$2.48M +54,000 New
SSA
71
Schonfeld Strategic Advisors
New York
$2.01M +$2.12M +46,055 +1,218%
AWM
72
Avitas Wealth Management
California
$1.87M +$2.13M +46,371 New
MCM
73
Marsico Capital Management
Colorado
$1.8M +$2.05M +44,565 New
Bank of America
74
Bank of America
North Carolina
$1.79M +$2.04M +44,356 +30,590%
HCM
75
Hodges Capital Management
Texas
$1.72M +$1.96M +42,675 New

GDRX Hedge Fund Activity: Q4 2020 in Review

192 of the 5,651 institutional investors tracked by Wall St. Rank reported a position in GoodRx Holdings (GDRX) for Q4 2020, worth a combined $5.14B — down 24% from $6.73B a quarter earlier.

Buyers outnumbered sellers: 107 funds opened new GDRX positions and 64 closed out — a net gain of 43 holders — while 51 added to existing stakes and 18 trimmed.

The largest buyer was Goldman Sachs, adding an estimated $104M. The largest seller was T. Rowe Price Associates, exiting entirely with an estimated $125M sold.

  • 192 institutional investors held GoodRx Holdings (GDRX) as of Q4 2020, up from 149 in Q3 2020.
  • Funds reported $5.14B of GoodRx Holdings stock for Q4 2020, down 24% quarter-over-quarter.
  • 107 funds opened new GoodRx Holdings positions in Q4 2020 and 64 closed out, a net change of +43 holders.
  • The largest GoodRx Holdings buyer in Q4 2020 was Goldman Sachs, an estimated $104M added.
  • The largest GoodRx Holdings seller in Q4 2020 was T. Rowe Price Associates, an estimated $125M sold.

Based on aggregated 13F filings for Q4 2020.